News & Press Releases

Eurofins Discovery Elevates Its Impact in San Diego’s Innovation Ecosystem by Enrolling as a Founding Sponsor of BioLabs, San Diego

SAN DIEGO — Eurofins Discovery announced a Founding Partner sponsorship agreement with BioLabs San Diego., providing support for premium wet lab and shared office facilities for early-stage life science entrepreneurs and developing first-in-class therapeutic tools and products with Eurofins DiscoverX.

Eurofins Acquires DiscoverX

Eurofins Pharma Discovery Services has acquired DiscoverX, enabling the expanded company to provide even more products, services, and integrated drug discovery projects from a single outsourcing provider.

Eurofins Expands its Offering and Footprint in Drug Discovery Services with the Acquisition of DiscoverX

The combination of Eurofins Pharma Discovery Services and DiscoverX provides the pharmaceutical and biotech industries with a partner of choice for end-to-end drug discovery services, DiscoverX’s KINOMEscan platform and epigenetics services, combined with Eurofins Pharma Discovery’s kinase profiling services would result in the largest available portfolio of kinase products and services in the market.

Rapidly Screen Molecules for Novel Immuno-Oncology Therapeutics with Checkpoint Receptor Screening and Profiling Services

Fremont, CA – DiscoverX Corporation launches PathHunter® checkpoint receptor screening and profiling services, providing validated assays for characterizing the increasing number of new immuno-oncology targets.

DiscoverX Launches Services for Early Identification of Potential Drug Side Effects

Announcing the launch of the SAFETYscan™ in vitro pharmacological profiling services

Easily Measure Cancer Cell Death in a Co-Culture with KILR™ Assays from DiscoverX

Announcing the launch of the KILR™ Cytotoxicity Assay

Displaying results 11-20 (of 52)
 |<  <  1 - 2 - 3 - 4 - 5 - 6  >  >|